Human Anti-AOC3 Recombinant Antibody (clone BTT-1002) (CAT#: NS-099CN)

The anti-Vap-1 antibody BTT-1002 is a chimeric antibody that recognizes a functional epitope of VAP-1.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA

Figure 1 The results of VAP-1 binding activity of the chimeric antibodies.

Figure 1 The results of VAP-1 binding activity of the chimeric antibodies.

The binding of the chimeric antibodies and an irrelevant control antibody (ctrAb) to Ax cells expressing human VAP-1 or mock control cells was analysed by flow cytometry. Results are expressed as percentage of maximal mean channel fluorescence (MCF);

Inhib

Figure 2 The inhibition of the lymphocyte binding by anti-VAP-1 antibodies.

Figure 2 The inhibition of the lymphocyte binding by anti-VAP-1 antibodies.

The abilities of the murine and chimeric antibodies to block the binding of lymphocytes to HEV were analysed using an in vitro frozen section assay. Sections were treated with anti-VAP-1 antibodies or with negative control antibodies (irrelevant monoclonal antibody 3G6 or human immunoglobulin). Results of two experiments are presented with their standard errors.

FC

Figure 3 The results of flow cytometric analysis of antibody binding to human Fcj/RI.

Figure 3 The results of flow cytometric analysis of antibody binding to human Fcj/RI.

B2KA cells expressing human FcγR\ on their surface were incubated with the mouse (A) and chimeric (B) anti-VAP-1 antibodies followed by appropriate detection reagents. A human lgG1 antibody was used as a positive control in B.

Figure 4 The serum concentrations after i.v. injection of chimeric anti-VAP-1 antibody, BTT-1002 (panel A) and murine anti-VAP-1 antibody (panel B);

Figure 4 The serum concentrations after i.v. injection of chimeric anti-VAP-1 antibody, BTT-1002 (panel A) and murine anti-VAP-1 antibody (panel B);

FuncS

Figure 5 The clinical score of BTT-1002 treated (panel A) and placebo treated (panel B) animals.

Figure 5 The clinical score of BTT-1002 treated (panel A) and placebo treated (panel B) animals.

FuncS

Figure 6 The survival of rhesus monkeys in the CIA study.

Figure 6 The survival of rhesus monkeys in the CIA study.


Specifications

  • Host Species
  • Human
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • Human IgG
  • Specificity
  • Human
  • Species Reactivity
  • Human
  • Clone
  • BTT-1002
  • Applications
  • ELISA, FC, IF, IHC, Inhib, FuncS
  • Related Disease
  • Chronic inflammatory diseases

Product Property

  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in Flow Cytometry, Inhibition, Functional Assay.

Target

  • Alternative Names
  • Amine Oxidase, Copper Containing 3; Semicarbazide-Sensitive Amine Oxidase; Vascular Adhesion Protein 1; Copper Amine Oxidase; EC 1.4.3.21; VAP-1; HPAO; SSAO; VAP1; Amine Oxidase, Copper Containing 3 (Vascular Adhesion Protein 1); Placenta Copper Monamine Oxidase; EC 1.4.3

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone BTT-1002"

See other products for "AOC3"

Chimeric Antibody

CAT Product Name Application Type
TAB-261 Anti-Human AOC3 Recombinant Antibody (Vapaliximab) WB, FC, IP, ELISA, Neut, FuncS, IF IgG2

Mouse Antibody

CAT Product Name Application Type
TAB-137 Anti-Human AOC3 Recombinant Antibody (Vepalimomab) Neut, ELISA, IF, IP, FuncS, FC, ICC IgM

Human Antibody

CAT Product Name Application Type
TAB-045CL Human Anti-AOC3 Recombinant Antibody (TAB-045CL) ELISA Human IgG
TAB-455CQ Anti-Human AOC3 Recombinant Antibody (Timolumab) ELISA, IHC, FC, IP, IF, FuncS IgG4, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0189 Hi-Affi™ Rabbit Anti-AOC3 Recombinant Antibody (clone DS189AB) IP, IHC-P, WB Rabbit IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-261 Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Vapaliximab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS ADCC enhanced antibody
AFC-TAB-455CQ Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Timolumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
AFC-TAB-137 Afuco™ Anti-AOC3 ADCC Recombinant Antibody (Vepalimomab), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for NS-099CN. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare